Related Experiment Videos

Microglia and the development of spongiform change in Creutzfeldt-Jakob disease

U v Eitzen1, R Egensperger, S Kösel

  • 1Institute of Neuropathology, Reference Center for Neurodegenerative Disorders, Ludwig-Maximilians-University, Munich, Germany.

Insights

Microglia activation in Creutzfeldt-Jakob disease (CJD) is linked to spongiform changes, but evidence suggests they are not early causal agents. Diseased microglia may contribute to neuronal injury and astrogliosis in later stages.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • In vitro studies suggest prion protein neurotoxicity depends on microglia presence.
  • Creutzfeldt-Jakob disease (CJD) is a fatal neurodegenerative disorder characterized by prion protein accumulation.
  • Microglia are the primary immune cells of the central nervous system.

Observation:

  • Studied 11 CJD cases using immunocytochemistry and computerized image analysis.
  • MHC class II-positive microglia were significantly increased (over 350-fold) in cortical gray matter of CJD patients.
  • Microglial distribution and morphology varied with spongiform degeneration patterns across cortical layers.

Findings:

  • Microglial activation correlated with spongiform change in layer V but less so in layers II/III.
  • In widespread spongiform degeneration, activated microglia showed atypical morphology and intracytoplasmic vacuoles, suggesting they may be disease targets.
  • Results provide indirect evidence against early microglial involvement in spongiform change initiation.

Implications:

  • Microglia are not likely early causative agents in CJD spongiform change.
  • Later-stage diseased microglia may produce factors mediating astrogliosis and neuronal injury.
  • Understanding microglial roles in CJD pathogenesis is crucial for developing therapeutic strategies.

Related Concept Videos